Nutrasource secures $2 mln in R&D funding from BDC Capital
BDC Capital has provided a non-dilutive facility of $2 million to Nutrasource Pharmaceutical and Nutraceutical Services, a Guelph, Ontario-based contract research organization for the health product and food sectors. The financing, BDC's sixth with Nutrasource, was completed through its Growth and Transition Capital group. Founded in 2002, Nutrasource provides regulatory, research and development (R&D), clinical trials and analytical testing solutions to help companies bring products to market. The facility's proceeds will be used for R&D spending eligible under Ottawa's Scientific Research and Experimental Development tax incentive program.
3 June 2019•3 mins read
